Supplier qualifications during Chinese drug quality audits are evaluated through a comprehensive review of documentation, compliance with Good Manufacturing Practices (GMP), on-site inspections, and risk assessments. Auditors assess the supplier’s quality management systems, production processes, and regulatory history to ensure they meet Chinese regulatory standards and maintain product safety and efficacy.